Is It Burnout or Perimenopause? Why Women in Their 40s Feel Exhausted, Anxious, and Not Like Themselves

You’re exhausted.

You can’t focus.

You feel anxious, overwhelmed, irritable, and like you’re running on empty.

You assume it’s stress. Maybe work has been demanding. Maybe you’re caring for children, aging parents, or trying to balance a hundred responsibilities at once.

Everyone tells you it’s burnout.

But what if it’s not just stress?

What if your body is going through a major hormonal transition that no amount of coffee, vacations, or self-care can fix?

For many women in their late 30s and 40s, the answer may be perimenopause.

The challenge is that perimenopause and burnout often look remarkably similar on the surface, making it difficult to know what’s actually causing your symptoms.

What Is Perimenopause?

Perimenopause is the transitional phase leading up to menopause when estrogen, progesterone, and testosterone begin to fluctuate. Contrary to popular belief, it doesn’t start when your periods stop.

Many women begin experiencing symptoms years before menopause, often while their menstrual cycles are still relatively regular.

Common symptoms include:

Fatigue
Brain fog
Anxiety
Mood swings
Sleep disturbances
Weight gain
Low libido
Changes in menstrual cycles

A 2026 global survey of more than 17,000 women across 158 countries found that fatigue (83%), exhaustion (83%), irritability (80%), depressed mood (77%), and anxiety (75%) were among the most commonly reported symptoms of perimenopause—often occurring before classic hot flashes.

What Is Burnout?

Burnout is a state of physical and emotional exhaustion caused by prolonged, unmanaged stress—often related to work, caregiving responsibilities, or chronic life demands.

The World Health Organization recognizes burnout as an occupational syndrome characterized by:

Feelings of energy depletion or exhaustion
Increased mental distance or negativity
Reduced effectiveness and productivity

Burnout is real and deserves attention. However, burnout is not a hormonal condition, and treating hormonal symptoms as “just stress” can leave women struggling for years without answers.

Why They’re So Easy to Confuse

Both burnout and perimenopause can cause:

Extreme fatigue
Brain fog
Anxiety
Difficulty concentrating
Mood changes
Poor sleep
Feeling disconnected from yourself

This overlap is one reason so many women are told their symptoms are simply stress-related.

The reality is that hormones influence how the brain responds to stress. During perimenopause, fluctuating estrogen levels can affect neurotransmitters and the body’s stress-response system, making women more vulnerable to anxiety, depression, and the effects of chronic stress.

10 Signs It Might Be Perimenopause Instead of Burnout

1. Your periods are changing

Heavier bleeding, lighter bleeding, irregular cycles, spotting, or worsening PMS can all be clues.

2. You’re waking up between 2 and 4 a.m.

Many women report suddenly developing sleep maintenance insomnia during perimenopause.

3. Your anxiety feels new

Even women who have never struggled with anxiety may suddenly notice racing thoughts or increased worry.

4. You’ve gained weight despite doing the same things

Particularly around the abdomen.

5. Your libido has changed

A decline in desire is often one of the earliest hormonal symptoms.

6. You feel more irritable than usual

Small frustrations seem bigger than they used to.

7. You experience night sweats or temperature changes

Even if you don’t have classic hot flashes.

8. Brain fog is affecting work or daily life

Forgetting names, losing words mid-sentence, or struggling to focus.

9. Alcohol affects you differently

Many women notice worsening sleep or anxiety after alcohol during perimenopause.

10. Rest isn’t helping

Burnout often improves when stress is reduced. Hormonal symptoms frequently persist even after vacations, weekends off, or improved work-life balance.

Could It Be Both?

Absolutely.

In fact, many women experience both simultaneously.

Perimenopause often occurs during one of the busiest periods of life. Careers, caregiving responsibilities, family obligations, and financial pressures may all be peaking at the same time hormones begin fluctuating.

Research suggests that hormonal changes can increase vulnerability to stress, while chronic stress can worsen hormonal symptoms. Together, they can create a cycle that leaves women feeling exhausted, overwhelmed, and unlike themselves.

Could It Be Something Else?

One of the biggest mistakes in healthcare is assuming fatigue always comes from hormones or stress.

Other common contributors include:

Low ferritin (iron stores)
Thyroid dysfunction
Vitamin D deficiency
Vitamin B12 deficiency
Insulin resistance
Sleep apnea
Chronic inflammation

This is why a comprehensive evaluation is often more valuable than looking at hormones alone.

🔥 Perimenopause Myths Debunked: What Women Need to Know

Myth #1: “Hormone therapy causes cancer.”

Let’s get real: This is the myth that changed women’s health for an entire generation.

Most of the fear comes from the Women’s Health Initiative (WHI) study published in 2002. However, the hormones used in that study are not the same hormones commonly prescribed today.

The WHI evaluated:

Conjugated equine estrogens (CEE/Premarin), derived from pregnant horse urine
Medroxyprogesterone acetate (MPA/Provera), a synthetic progestin

The study did not evaluate bioidentical estradiol or micronized progesterone, which are commonly prescribed today.

Long-term follow-up demonstrated that estrogen-only therapy did not increase breast cancer mortality and was associated with lower breast cancer mortality in some populations. Increased breast cancer risk was primarily associated with the combination of CEE and synthetic progestin.

Modern evidence suggests that estradiol and micronized progesterone have a more favorable safety profile than the hormones used in the original WHI study.

The bottom line: Hormone therapy is not one-size-fits-all. The type of hormone, dose, route of administration, timing, and patient selection all matter.

Myth #2: “You don’t need testosterone—it’s a man’s hormone.”

Let’s get real: Women naturally produce testosterone throughout life.

Testosterone contributes to:

Sexual desire
Arousal
Motivation
Muscle maintenance
Recovery
Overall well-being

Current evidence supports testosterone therapy primarily for women with hypoactive sexual desire disorder (HSDD).

Testosterone isn’t “just a male hormone,” but it also isn’t a cure-all. Appropriate dosing, monitoring, and patient selection are essential.

Myth #3: “I’m on testosterone and my blood counts went up—just take an aspirin.”

Let’s get real: Testosterone can increase hemoglobin and hematocrit because it stimulates red blood cell production. That’s why routine monitoring is important.

However, aspirin is not a treatment for testosterone-related erythrocytosis.

Many people confuse testosterone-induced increases in hematocrit with polycythemia vera, a completely different bone marrow disorder where aspirin may play a role in reducing clotting risk.

If hematocrit becomes elevated on testosterone therapy, the appropriate response is usually:

Reassessing testosterone levels
Adjusting the dose
Evaluating the delivery method
Considering alternative formulations

Simply adding aspirin does not address the underlying issue.

Myth #4: “Perimenopause is just hot flashes.”

Let’s get real: Hot flashes get all the attention, but they are not the most common symptom.

Research shows fatigue, exhaustion, irritability, anxiety, depressed mood, and brain fog are among the most frequently reported symptoms.

Many women go through perimenopause without significant hot flashes but still struggle with sleep, mood, cognition, and energy.

Myth #5: “I’m too young for perimenopause.”

Let’s get real: Perimenopause can begin in the late 30s or early 40s.

Many women spend years searching for answers before realizing hormones may be contributing to their symptoms.

If you’re 38, 40, or 42 and suddenly experiencing fatigue, sleep disruption, anxiety, brain fog, or menstrual changes, perimenopause deserves consideration.

Myth #6: “Hormone Testing Can Diagnose or Rule Out Perimenopause”

Let’s get real: This is one of the biggest misconceptions in women’s health.

Many women come into the clinic expecting a single blood test to tell them whether they’re in perimenopause. Unfortunately, it isn’t that simple.

During perimenopause, estrogen and progesterone don’t decline in a straight line—they fluctuate dramatically. One week your estrogen may be elevated, and the next week it may be significantly lower. Because of these fluctuations, a single hormone level often cannot diagnose or exclude perimenopause.

Understanding Common Hormone Reference Ranges

Hormone Marker	Cycle Phase / Stage	Typical Reference Range
Estradiol (E2)	Follicular Phase	~30–120 pg/mL
	Ovulatory Peak	~130–370 pg/mL
	Luteal Phase	~70–250 pg/mL
	Postmenopause	Typically <20–30 pg/mL
Progesterone	Follicular Phase	Usually <1 ng/mL
	Luteal Phase	Approximately 5–20 ng/mL
	Postmenopause	Usually <1 ng/mL
FSH (Follicle-Stimulating Hormone)	Premenopause	Approximately 4–20 mIU/mL
	Menopause	Often >25–30 mIU/mL

The challenge is that women in perimenopause may move in and out of these ranges depending on where they are in their cycle. A woman can have symptoms of perimenopause and still have hormone levels that appear “normal” on a lab report.

This is why many menopause experts diagnose perimenopause primarily based on symptoms and menstrual cycle changes rather than relying solely on hormone testing.

Hormone testing can still be valuable, especially when evaluating other conditions that may contribute to fatigue, brain fog, mood changes, or weight gain. Depending on the situation, your provider may also evaluate thyroid function, ferritin (iron stores), vitamin D levels, metabolic health, and other hormone markers.

The bottom line: A normal hormone panel does not automatically rule out perimenopause. Your symptoms, cycle history, sleep patterns, and overall health matter just as much as the numbers on a lab report.

What Should You Do?

If you’re a woman over 35 experiencing persistent fatigue, brain fog, anxiety, sleep disruption, mood changes, or feeling unlike yourself:

Track your symptoms and cycle
Prioritize sleep and stress management
Discuss symptoms with a healthcare professional
Don’t assume it’s “just stress”
Consider a comprehensive evaluation
Look beyond hormones alone

The goal isn’t simply to blame hormones. The goal is to identify the root cause.

The Bottom Line

Fatigue, brain fog, anxiety, and mood changes during midlife are not something you simply have to “push through.”

Whether the answer is burnout, perimenopause, low ferritin, thyroid dysfunction, poor sleep, chronic stress, or a combination of factors, understanding the root cause is the first step toward feeling like yourself again.

And if you’ve been wondering whether what you’re experiencing is normal, you’re not alone.

The good news is that answers—and treatment options—exist.

References

Hedges MS, Hewings-Martin Y, Karam J, et al. Global Perspectives on Perimenopause: A Digital Survey of Knowledge and Symptoms Using the Flo Application. Menopause. 2026.
Aras SG, Grant AD, Konhilas JP. Clustering of >145,000 Symptom Logs Reveals Distinct Pre-, Peri-, and Menopausal Phenotypes. Scientific Reports. 2025.
Kuck MJ, Hogervorst E. Stress, Depression, and Anxiety: Psychological Complaints Across Menopausal Stages. Frontiers in Psychiatry. 2023.
Maki PM, Kornstein SG, Joffe H, et al. Guidelines for the Evaluation and Treatment of Perimenopausal Depression. Journal of Women’s Health. 2019.
Maki PM, Weber MT, Engelman CD. Perimenopause, Cognition, and Mood: Current Evidence and Clinical Implications. American Journal of Psychiatry. 2024.
Crandall CJ, Mehta JM, Manson JE. Management of Menopausal Symptoms: A Review. JAMA. 2023.
Manson JE, Crandall CJ, Rossouw JE, et al. The Women’s Health Initiative Randomized Trials and Clinical Practice: A Review. JAMA. 2024.
Chlebowski RT, Anderson GL, Aragaki AK, et al. Association of Menopausal Hormone Therapy With Breast Cancer Incidence and Mortality During Long-Term Follow-Up of the Women’s Health Initiative Randomized Clinical Trials. JAMA. 2020.
Bofill Rodriguez M, Yong LN, Mirkov S, et al. Long-Term Hormone Therapy for Perimenopausal and Postmenopausal Women. Cochrane Database of Systematic Reviews. 2025.
Bollam R, Karam J, Shufelt C, Faubion SS. Menopausal Hormone Therapy and Breast Cancer: Balancing Risks and Benefits. Maturitas. 2026.
Collaborative Group on Hormonal Factors in Breast Cancer. Type and Timing of Menopausal Hormone Therapy and Breast Cancer Risk: Individual Participant Meta-analysis of the Worldwide Epidemiological Evidence. Lancet. 2019.
Gartlehner G, Patel SV, Reddy S, et al. Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2022.
National Academies of Sciences, Engineering, and Medicine. The Clinical Utility of Compounded Bioidentical Hormone Therapy: A Review of Safety, Effectiveness, and Use. Washington, DC: National Academies Press; 2020.
Davis SR, Baber R, Panay N, et al. Global Consensus Position Statement on the Use of Testosterone Therapy for Women. Journal of Clinical Endocrinology & Metabolism. 2019.
Kling JM. Testosterone for the Treatment of Hypoactive Sexual Desire Disorder in Perimenopausal and Postmenopausal Women. Obstetrics & Gynecology. 2025.
Pilnik S, Belardo A, Marchesan LB, et al. Androgen Therapy in Midlife and Older Women: A Position Statement of the Latin American Association of Gynecological Endocrinology (ALEG). Climacteric. 2025.
Tienforti D, Pastori D, Barbonetti A. Effects of Testosterone Therapy on Coagulation and Hematological Parameters: A Systematic Review and Meta-analysis. Thrombosis Research. 2024.
Dandona P, Dhindsa S, Ghanim H, Saad F. Mechanisms Underlying the Metabolic Actions of Testosterone in Humans: A Narrative Review. Diabetes, Obesity and Metabolism. 2021.
White J, Petrella F, Ory J. Testosterone Therapy and Secondary Erythrocytosis. International Journal of Impotence Research. 2022.
Rhoden EL, Morgentaler A. Risks of Testosterone-Replacement Therapy and Recommendations for Monitoring. New England Journal of Medicine. 2004.
Landolfi R, Marchioli R, Kutti J, et al. Efficacy and Safety of Low-Dose Aspirin in Polycythemia Vera. New England Journal of Medicine. 2004.
Tremblay D, Kremyanskaya M, Mascarenhas J, Hoffman R. Diagnosis and Treatment of Polycythemia Vera: A Review. JAMA. 2025.
World Health Organization. International Classification of Diseases, 11th Revision (ICD-11). Burnout (Code QD85). Geneva: WHO; 2019.
Maslach C, Leiter MP. Understanding the Burnout Experience: Recent Research and Its Implications for Psychiatry. World Psychiatry. 2016.